Over 30 million psychedelic users in the United States

We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychede...

Descripción completa

Detalles Bibliográficos
Autores principales: Krebs, Teri S, Johansen, Pål-Ørjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2013
Materias:
Short Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917651/
https://www.ncbi.nlm.nih.gov/pubmed/24627778
http://dx.doi.org/10.12688/f1000research.2-98.v1
_version_ 1782302875329757184
author Krebs, Teri S
Johansen, Pål-Ørjan
author_facet Krebs, Teri S
Johansen, Pål-Ørjan
author_sort Krebs, Teri S
collection PubMed
description We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).
format Online
Article
Text
id pubmed-3917651
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-39176512014-03-12 Over 30 million psychedelic users in the United States Krebs, Teri S Johansen, Pål-Ørjan F1000Res Short Research Article We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females). F1000Research 2013-03-28 /pmc/articles/PMC3917651/ /pubmed/24627778 http://dx.doi.org/10.12688/f1000research.2-98.v1 Text en Copyright: © 2013 Krebs TS et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Research Article
Krebs, Teri S
Johansen, Pål-Ørjan
Over 30 million psychedelic users in the United States
title Over 30 million psychedelic users in the United States
title_full Over 30 million psychedelic users in the United States
title_fullStr Over 30 million psychedelic users in the United States
title_full_unstemmed Over 30 million psychedelic users in the United States
title_short Over 30 million psychedelic users in the United States
title_sort over 30 million psychedelic users in the united states
topic Short Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917651/
https://www.ncbi.nlm.nih.gov/pubmed/24627778
http://dx.doi.org/10.12688/f1000research.2-98.v1
work_keys_str_mv AT krebsteris over30millionpsychedelicusersintheunitedstates
AT johansenpalørjan over30millionpsychedelicusersintheunitedstates

Ejemplares similares